Instructions for Authors

PHARMACEUTICAL REVIEWS (ISSN 1918-5561)

Official publication of Pharmainfo.net, Canada

Instruction to authors

Review articles should bring up the most important current topics or present interpretative and critical accounts. Manuscripts are accepted on the understanding that the authors have obtained the necessary authority for publication. Manuscripts with multi-authors imply the consent of each of the authors. Submission of an article to “Pharmaceutical Reviews” is understood to imply that it has not been either published or not being considered for publication elsewhere. Manuscripts should be neatly typed, double-spaced throughout, including tables, graphs, figures. Manuscript should be uniform size with at least 2.5 cm margins on all sides.

Prepare the manuscript in Times New Roman font using a font size of 12. Title shall be in a font size 14, bold face capitals. All section titles in the manuscript shall be in font size 12, bold face capitals. Subtitles in each section shall be in font size 12, bold face lower case. Standard International Units could be used throughout the text. Pages should be numbered, manuscript should be starting with the title page and the text should be arranged in the following order: Title page, Abstract, Introduction, Subsections, Future prospects, Acknowledgements, References, Figure and Table. Complete file should be submitted to the e-mail: articles @ pharmainfo.net.

Title Page:

The title must be as brief as possible, comprehensive and descriptive. Each author must provide their full name including their forenames and surname followed by their address in normal face lower case. The Corresponding Author of the manuscript must be marked with an asterisk, and should be listed first. In addition the corresponding author must include telephone, fax and E-mail address at the bottom left corner of the title page. If any of the co-authors are from different organizations, their addresses too should be mentioned and indicated using numbers after their names.

Abstract:

Should start on a new page after the title page and should present the reason of the study, the main findings, and principal conclusions, not more than 250 words.

Keywords: 3-6 keywords are to be provided by the authors.  
Introduction: Should start on a new page and should clearly introduce the topic and subtopics thereof in subsequent subheadings.

Future Prospects: Should contain a critical review of the manuscript and topic with authors view on the future prospects of the topic. It can end with brief conclusions.  
Acknowledgements: All acknowledgments should be typed in one paragraph directly preceding the reference section.

References: References should be referred to by number. Nothing should be italicized.

Typical Paper Reference:

Gupta H, Jain S, Mathur R, Mishra P, Mishra AK, Velpandian T. Sustained ocular drug delivery from a temperature and pH triggered in-situ gel system, Drug Delivery 2007, 14(8), 507-515.

Typical Chapter Reference:

Singh J, Maibach HI, Walters KA (ed.), Transdermal delivery and cutaneous reactions; In: Dermatological and Transdermal Formulations. New York, Marcel Dekker.2001; 529-547.

Meeting Abstract:

Rangaramanujam K. Design of dendrimer-based drug delivery nanodevices with enhanced therapeutic efficacies. 2007 APS March Meeting., Colorado, USA (2007).

Patent Reference Style:

Ternansky, R.J., Mazar, A., Gladstone, P.L., Coucouvanis, D., Allan, A.L., O’Hare, S.M., Price, M.L.P., Pirie-Shepherd, S.R., Donate, F.: US20077189865 (2007).

Abstracts, unpublished data and personal communications (which can only be included if prior permission has been obtained) should not be given in the reference section but they may be mentioned in the text and details provided as footnotes.

Complete file should be submitted with Copyright Form   form through e-mail: articles @ pharmainfo.net.

Click Here to Download Copyright Form

If you have any questions, comments, concerns, or problems contact: articles @ pharmainfo.net